-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
This article is from NEJM Journal Watch Phase 1 Oncology Trials: Improved Outcomes Over Time
Phase 1 Oncology Trials: Improving
Outcomes Over Time Review by William J.
.
"NEJM Medical Frontiers" translates several times a week, publishes them on the app and official website, and selects 2-3 articles to be published
on WeChat.
Copyright informationThis article was translated, authored or commissioned
by the Jiahui Medical Research and Education Group (J-Med) and the New England Journal of Medicine (NEJM), which is jointly developed by the New England Journal of Medicine (NEJM).
The full text of the Chinese translation and the charts contained therein are exclusively authorized
by NEJM Group.
If you need to reprint, please leave a message or contact nejmqianyan@nejmqianyan.
cn
.
Unauthorized translation is an infringement and the copyright owner reserves the right to
pursue legal liability.
Phase 1 Oncology Trials: Improving
Outcomes Over Time Review by William J.
NEJM Journal Collection
NEJM Journal Watch, published by NEJM Group, invites internationally renowned physicians to review important papers in the field of medicine and help physicians understand and apply the latest advances.
"NEJM Medical Frontiers" translates several times a week, publishes them on the app and official website, and selects 2-3 articles to be published
on WeChat.
Copyright informationThis article was translated, authored or commissioned
by the Jiahui Medical Research and Education Group (J-Med) and the New England Journal of Medicine (NEJM), which is jointly developed by the New England Journal of Medicine (NEJM).
The full text of the Chinese translation and the charts contained therein are exclusively authorized
by NEJM Group.
If you need to reprint, please leave a message or contact nejmqianyan@nejmqianyan.
cn
.
Unauthorized translation is an infringement and the copyright owner reserves the right to
pursue legal liability.